Condition
Uterine Fibroids (Leiomyoma)
Total Trials
4
Recruiting
2
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 4 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
3Total
Not Applicable (3)
Trial Status
Recruiting2
Active Not Recruiting1
Not Yet Recruiting1
Clinical Trials (4)
Showing 4 of 4 trials
NCT07480785Not ApplicableRecruitingPrimary
TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk Patients
NCT07474688Active Not RecruitingPrimary
Laparoscopic Myomectomy Based on a Fully Enclosed Protective Device: A Novel Surgical Technique Achieving Tumor-Free Protection Throughout the Entire Procedure
NCT07352761Not ApplicableRecruitingPrimary
Bilateral Uterine Artery Occlusion During Laparoscopic Myomectomy
NCT07235787Not ApplicableNot Yet RecruitingPrimary
Efficacy of Ultrasound Guided Microwave Ablation in the Treatment of Uterine Fibroids.
Showing all 4 trials